Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Pharmadrug Inc C.PHRX

Alternate Symbol(s):  LMLLF

PharmaDrug Inc. is a Canada-based specialty pharmaceutical company. The Company is focused on the research, development and commercialization of controlled-substances and natural medicines, such as psychedelics and previously approved drugs. The Company’s subsidiary, Sairiyo Therapeutics (Sairiyo), is a biotech company that specializes in researching and reformulating established natural medicines. Sairiyo is engaged in the development of its patented reformulation of cepharanthine, a drug that has shown substantial third party validated potential for the treatment of infectious diseases and rare cancers. Sairiyo is also conducting research and development (R&D) in the psychedelics space for the treatment of non-neuropsychiatric conditions. The Company also operates through SecureDose Synthetics Inc., which is a pharmaceutical research and development company focused on the development of synthetic formulations of existing drugs for potential commercialization and distribution.


CSE:PHRX - Post by User

Comment by SamRothsteinon Jan 12, 2021 9:08am
114 Views
Post# 32274500

RE:LOL

RE:LOLWe all know you think private placements are bad, issuing stock to do a deal is bad, Terry booth is bad, and that Booth destroyed ACC.  The fact is that Booth took ACB from $2.43 on Aug.21, 2017 to $13.48 on Jan 15 , 2018.  That is a 454.73% return in 6 months.  I know you consider that a failure because the stock (along with entire mj sector ) corrected sharply after that parabolic rise.  We are going to have to agree to disagree on this point.  I consider a 454% return in six months to be a good thing, at least for my purpose, and I welcome you to continue to consider that a failure.  



Lowfloatmining1 wrote:

Hey pumpers how does it feel that the company just issued another 75million shares to an already bloated float? 

Spend away using shares but don't worry about making some actual money. This was the material news right fishcat... you said they were going to release news about their new superstore instead they used shares to buy another company. 

Wonder if this has terry booths finger prints on it. This is exactly what he did with Acb and diluted that company to oblivion. Over pay for everything with shares! 

Let's see how you clowns will spin this. 



<< Previous
Bullboard Posts
Next >>